I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Efficacy, safety and patient reported outcomes in patients ..:
Manchon, Eric
;
Laplaud, David
;
Vukusic, Sandra
...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.msard.2022.104109. , 2022
Link:
https://inserm.hal.science/inserm-03854049
RT Journal T1
Efficacy, safety and patient reported outcomes in patients with active relapsing multiple sclerosis treated with ocrelizumab: Final results from the PRO-MSACTIVE study
UL https://suche.suub.uni-bremen.de/peid=base-ftunivcotedazur:oai:HAL:inserm-03854049v1&Exemplar=1&LAN=DE A1 Manchon, Eric A1 Laplaud, David A1 Vukusic, Sandra A1 Labauge, Pierre A1 Moreau, Thibault A1 Kobelt, Gisela A1 Grouin, Jean-Marie A1 Lotz, Marie A1 Pau, David A1 Christine, Lebrun, Frenay PB HAL CCSD; Elsevier YR 2022 K1 Ocrelizumab K1 Phase IV K1 Relapsing multiple sclerosis K1 [SDV]Life Sciences [q-bio] JF info:eu-repo/semantics/altIdentifier/doi/10.1016/j.msard.2022.104109 LK http://dx.doi.org/https://inserm.hal.science/inserm-03854049 DO https://inserm.hal.science/inserm-03854049 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)